Kerry A. Ryan, Shirley Cohen-Mekelburg, Jessica A. Baker, Eileen M. Weinheimer-Haus, Chris Krenz, Jason K. Hou, . . . Akbar K. Waljee. (2024). Public deliberation to assess patient views on biosimilar medication switching for the treatment of inflammatory bowel disease. BMC.
Chicago Style (17th ed.) CitationKerry A. Ryan, Shirley Cohen-Mekelburg, Jessica A. Baker, Eileen M. Weinheimer-Haus, Chris Krenz, Jason K. Hou, Raymond De Vries, and Akbar K. Waljee. Public Deliberation to Assess Patient Views on Biosimilar Medication Switching for the Treatment of Inflammatory Bowel Disease. BMC, 2024.
MLA (9th ed.) CitationKerry A. Ryan, et al. Public Deliberation to Assess Patient Views on Biosimilar Medication Switching for the Treatment of Inflammatory Bowel Disease. BMC, 2024.